JOIN US
Participants
Participants at the Convergence Forum include an invitation-only group of company founders, senior level executives, investors and healthcare leaders along with a select group of service providers who sponsor the program. Request an invitation or call us at 833-437-1400 if you would like to join us.
Companies JOINING US at the 2025 Convergence Forum include:
1910 Genetics
Absco Therapeutics
Alexandria
Alloy Therapeutics
Andreessen Horowitz
Antlia Bioscience
Aquilo Partners
Arbor Biotechnologies
Arcturus Therapeutics
Arena BioWorks
Arrakis Therapeutics
AstraZeneca
Atlas Venture
Axonis Therapeutics
Banc of California
Bectas Therapeutics
BIAL Biotech
BioAge
Blackbird Laboratories
Boston Children’s Hospital
Breakout Ventures
Broad Institute
CEC Capital Group
Citizens Private Bank
Concerto Biosciences
DeepLook Medical
Delix Therapeutics
Delphia Therapeutics
DLA Piper
Droplet Biosciences
Eikonizo Therapeutics
Eledon Pharmaceuticals
EMD Serono
Entact Bio
Entrada Therapeutics
Enveda
Envy
Ernest Pharmaceuticals
Evotec
Fidelity Private Shares
F-Prime Biomedical Research Initiative
Flagship Pioneering
Foreground Capital
Garuda Therapeutics
General Proximity
GlycoMimetics
Gordian Ventures
GrayBella Capital
GV
Halloran Consulting Group
Harvard Medical School
HC Bioscience
HDAX Therapeutics
Hevolution
Icahn School of Medicine at Mt Sinai
Immunscope
Incubate Coalition
Ipsen
Jefferson River Capital
Johnson & Johnson Innovation -
JJDC
KiraGen Bio
Kojin Therapeutics
Kynexis THerapeutics
Larkspur Biosciences
Longevity Physician
Lucy Therapeutics
Luminary Therapeutics
Lumira Ventures
Lybra Bio
Lyndra Therapeutics
Lytica Therapeutics
Martrisome Bio
MedTech Color
Mendus
Merck
Mineralys Therapeutics
Morphoceuticals
MRL Ventures Fund
National Venture Capital Association ·
Neptune Bio
NextRNA Therapeutics
Nocion Therapeutics
Normunity
Nova Nordisk
Novita Pharmaceuticals
Nucleate
Orionis Biosciences
Owkin
Oxford Finance
PAQ Therapeutics
Pending AI
Riboway Therapeutics
Pretzel Therapeutics
Psivant Therapeutics
RA Capital Management
Rapport Therapeutics
ReConstruct Bio
ROME Therapeutics
Sanofi
Sante
Satellite Bio
Seaport Therapeutics
Sena Therapeutics
Sensorium Therapeutics
SLAM BioTherapeutics
Souffle
SpyBiotech
Syntis Bio
Takeda
Talus Bio
Tornado Therapeutics
Transcera
Two Bear Capital
Vertex Ventures HC
Verve Therapeutics
Veru
Vigil Neuroscience
Voltron Therapeutics
WilmerHale
Women's Digital Health Network
Worldwide Clinical Trials
X4 Pharmaceuticals